United Kingdom research governance strategy

BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7430.49-b (Published 01 January 2004) Cite this as: BMJ 2004;328:49

Reforming clinical research and development in England

  1. Richard Sullivan, head, clinical programmes (richard.sullivan@cancer.org.uk)
  1. Cancer Research UK, London WC2A 3PX

    EDITOR—The National Cancer Research Institute does not set the research strategies of its partners, as Kerrison et al say.1 They also do not grasp its mission, which is to double the number of patients entering cancer clinical trials by 2005 (a target it has already surpassed).

    They suggest that the formal research networks in cancer were set up as a result of the outcomes of the Pharmaceutical Industry Competitiveness Taskforce. The institute was created …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription